Volume 14, Number 5—May 2008
Research
Increasing Hospitalizations and General Practice Prescriptions for Community-onset Staphylococcal Disease, England
Andrew Hayward*
, Felicity Knott*, Irene Petersen*, David M. Livermore†, Georgia Duckworth†, Amir Islam*, and Anne M. Johnson*
, Felicity Knott*, Irene Petersen*, David M. Livermore†, Georgia Duckworth†, Amir Islam*, and Anne M. Johnson*
Table 1
Comparison of trends in hospital admissions, England, 1989–90 to 2003–04*
| Type of infection and ICD codes |
No. admissions
(age-standardized admission
rate per 100,000 population) |
Standardized admission ratios (95% CI) |
||
|---|---|---|---|---|
| Acute community-onset infections likely to be caused by staphylococci (ICD-9: ICD-10 codes) | 1989–90 | 2003–04 | 2003–04 vs. 1989–90 | |
| Abscess, carbuncle, and furuncle and/or cellulitis (6800–6811, 6819–6829: L02.0–L03.9) | 23,884 (50.0) | 74,447(148.8) | 2.98 (2.96–3.00) | |
| Bone and joint infection (7300–7309, 7110: M86.0– M86.6, M86.8, M86.9, M00.0–M00.2,M00.8,M00.9) | 4,104 (8.9) | 6,700 (13.4) | 1.57 (1.53–1.60) | |
| Staphylococcal septicemia (381: A41.0–A41.2) | 249 (0.5) | 1,681 (3.3) | 6.39 (6.10–6.71) | |
| Impetigo (684: L01.0,L01.1) | 199 (0.4) | 1,108 (2.5) | 5.92 (5.58–6.28) | |
| Staphylococcal pneumonia (4824: J15.2) | 109 (0.2) |
568 (1.2) |
5.04 (4.64–5.47) |
|
| 1995–96 |
2003–04 |
2003–04 vs. 1995–96 |
||
| Cellulitis (NA: L03.0–L03.9) | 24,388 (50.3) | 49,980 (98.9) | 1.97 (1.95–1.98) | |
| Abscess, carbuncle, and furuncle (NA: L02.0–L02.9) | 12,675 (26.1) | 24,467 (49.3) | 1.89 (1.86–1.91) | |
| Staphylococcal scalded-skin syndrome (NA: L00.X) |
149 (0.3) |
747 (1.6) |
5.27 (4.91–5.63) |
|
| Acute community-onset control conditions (ICD-9: ICD-10 codes) |
1989–90 |
2003–04 |
2003–04 vs. 1989–90 |
|
| Forearm fracture (8130–8135:S520–S529) | 30,272 (63.2) | 54,089(106.9) | 1.69 (1.01–1.68) | |
| Acute appendicitis (5400–5409, K35.0–K35.9) | 30,946 (64.6) | 30,324 (61.5) | 0.95 (0.94–0.96) | |
| Ingrown toenail (7030:L60.0) | 16,606 (34.7) | 11,182 (22.7) | 0.65 (0.64–0.67) | |
| Other septicemias (380–384, 388,389: A400–A409, A414, A415, A418, A419 | 3,793 (7.9) | 12,873 (24.9) | 3.15 (3.10–3.20) | |
| Gastroenteritis/diarrhea of presumed infectious origin (91: A09.X) | 8,416 (17.6) | 6,528 (14.3) | 0.81 (0.79–0.83) | |
| Cholecystitis (5750: K81.0) | 3,171 (6.6) | 4,264 (8.3) | 1.25 (1.21–1.28) | |
| Conjunctivitis (3720–3724:H10.0–H10.9) | 639 (1.3) | 193 (0.3) | 0.33 (0.29–0.38) | |
| Viral pneumonia (4800–4809:J12.0–J12.9) | 585 (1.2) | 501 (1.1) | 0.88 (0.81–0.96) | |
| Erysipelas (35:A46.X) | 373 (0.8) | 357 (0.7) | 0.89 (0.80–0.99) | |
*Years are financial years, April 1 to March 31. CI, confidence interval; ICD, International Classification of Diseases; NA, not available.
Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.